Trial Profile
Localized Effects of Photobiomodulation and Exogenous Nitric Oxide on CREST Patients Calcinosis Cutis and Raynaud Phenomenon
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Nitric oxide (Primary)
- Indications Calcinosis; Oesophageal motility disorders; Pain; Raynaud's disease; Sclerodactyly; Telangiectasis
- Focus Pharmacodynamics; Therapeutic Use
- 06 Jun 2019 New trial record